Author

Bram Verstockt 1

1 University Hospitals Leuven,Department of Gastroenterology and Hepatology,Leuven,Belgium

A DRUG-RESISTANT ASSAY CAN BETTER DIRECT THE NEED FOR ADALIMUMAB DOSE-ESCALATION AFTER INDUCTION THERAPY IN ANTI-TNF NAÏVE PATIENTS WITH CROHN’S DISEASE

Gitte Moors, Bram Verstockt, Sumin Bian, Sophie Tops, Vera Ballet, Gert Van Assche, Severine Vermeire, Ann Gils, Marc Ferrante

ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment

Joana Torres, Stefanos Bonovas, Glen A Doherty, Torsten Kucharzik, Javier Gisbert, Tim Raine, Michel Adamina, Alessandro Armuzzi, Oliver Bachmann, Palle Bager, Livia Biancone, Bernd Bokemeyer, Peter Bossuyt, Johan Burisch, Paul Collins, Alaa El-Hussuna, Pierre Ellul, Cornelia Frei-Lanter, Federica Furfaro, Christian Gingert, Paolo Gionchetti, Fernando Gomollón, Marien González-Lorenzo, Hannah Gordon, Tibor Hlavaty, Pascal Juillerat, Konstantinos H. Katsanos, Uri Kopylov, Eduards Krustins, Theodore Lytras, Christian Maaser, Fernando Jose Magro Dias, John K. Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, João Sabino, Edoardo Vincenzo Savarino, Antonino Spinelli, Laurents Stassen, Mathieu Uzzan, Stephan Vavricka, Bram Verstockt, Janindra Warusavitarne, Oded Zmora, Gionata Fiorino

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

Christian Maaser, Andreas Sturm, Stephan Vavricka, Torsten Kucharzik, Gionata Fiorino, Vito Annese, Emma Calabrese, Daniel C. Baumgart, Dominik Bettenworth, Paula Borralho-Nunes, Johan Burisch, Fabiana Castiglione, Abraham (Rami) Eliakim, Pierre Ellul, Iago González Lama, Hannah Gordon, Steve Halligan, Konstantinos H. Kats

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects

Andreas Sturm, Christian Maaser, Emma Calabrese, Vito Annese, Gionata Fiorino, Torsten Kucharzik, Stephan Vavricka, Bram Verstockt, Patrick Van Rheenen, Damian Tolan, Stuart Taylor, Jordi Rimola, Florian Rieder, Jimmy K. Limdi, Andrea Laghi, Eduards Krustins, Paulo Gustavo Kotze, Uri Kopylov, Konstantinos H. Katsanos, St

EFFECTIVENESS OF USTEKINUMAB AS INDUCTION THERAPY FOR CHRONIC ANTIBIOTIC REFRACTORY POUCHITIS

An Outtier, Edouard Louis, Olivier Dewit, Ganel Schops, João Sabino, Bram Verstockt, Severine Vermeire, Marc Ferrante

ENDOSCOPIC AND HISTOLOGIC REMISSION IN TOFACITINIB TREATED REFRACTORY MODERATE-TO-SEVERE PATIENTS WITH ULCERATIVE COLITIS: A PROSPECTIVE REAL-LIFE COHORT

Bram Verstockt

ENDOSCOPIC AND HISTOLOGIC REMISSION IN TOFACITINIB TREATED REFRACTORY MODERATE-TO-SEVERE PATIENTS WITH ULCERATIVE COLITIS: A PROSPECTIVE REAL-LIFE COHORT

Bram Verstockt, An Outtier, Jolien Lefrère, João Sabino, Severine Vermeire, Gert De Hertogh, Marc Ferrante

EXPOSURE TO AN INFLAMMATORY MIX RE-INDUCES INFLAMMATION IN ORGANOIDS OF ULCERATIVE COLITIS PATIENTS, INDEPENDENT OF THE INFLAMMATORY STATE OF THE TISSUE OF ORIGIN

Kaline Arnauts, Bram Verstockt, João Sabino, Severine Vermeire, Catherine Verfaillie, Marc Ferrante

HEALTH LITERACY, QUALITY OF LIFE, WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN YOUNG ADULTS WITH CROHN'S DISEASE COMPARED TO DIABETES MELLITUS PATIENTS: LONG-TERM FOLLOW-UP FROM THE BELGIAN CROHN'S DISEASE REGISTRY

Constance Carels, Lucas Wauters, Filip Baert, Peter Bossuyt, Bruno Hauser, Robert Hilbrands, Ilse Hoffman, Bart Keymeulen, An Outtier, Isabelle Paquot, Isabelle Ruytjens, Marc Simoens, Clara Thienpont, Annelies Verreth, Bram Verstockt, Severine Vermeire, Gigi Veereman

Identification of biomarkers and mechanistic insight for upadacitinib in Crohn's disease: Serum inflammatory mediator analysis from the Phase 2b CELEST study

Severine Vermeire, Heath M. Guay, Bram Verstockt, Feng Hong, Wan-Ju Lee, Fabio Cataldi, Ana P. Lacerda, Silvio Danese

Item 1 - 10 / 25
1
2 3